PDB Short entry for 3TGM HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 17-AUG-11 3TGM TITLE X-RAY CRYSTAL STRUCTURE OF HUMAN HEME OXYGENASE-1 IN COMPLEX WITH 1- TITLE 2 (1H-IMIDAZOL-1-YL)-4,4-DIPHENYL-2 BUTANONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEME OXYGENASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 1-233; COMPND 5 SYNONYM: HO-1; COMPND 6 EC: 1.14.99.3; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HMOX1, HO, HO1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 668369; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DH5-ALPHA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: DELTA233-HHO-1 KEYWDS ALPHA HELIX, OXIDOREDUCTASE, HEME, MICROSOMES, OXIDOREDUCTASE- KEYWDS 2 OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.N.RAHMAN,Z.JIA REVDAT 3 13-SEP-23 3TGM 1 REMARK LINK REVDAT 2 15-FEB-12 3TGM 1 JRNL REVDAT 1 01-FEB-12 3TGM 0 JRNL AUTH M.N.RAHMAN,J.Z.VLAHAKIS,D.VUKOMANOVIC,W.LEE,W.A.SZAREK, JRNL AUTH 2 K.NAKATSU,Z.JIA JRNL TITL A NOVEL, "DOUBLE-CLAMP" BINDING MODE FOR HUMAN HEME JRNL TITL 2 OXYGENASE-1 INHIBITION. JRNL REF PLOS ONE V. 7 29514 2012 JRNL REFN ESSN 1932-6203 JRNL PMID 22276118 JRNL DOI 10.1371/JOURNAL.PONE.0029514 REMARK 2 REMARK 2 RESOLUTION. 2.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.82 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 10516 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.225 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 554 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.92 REMARK 3 REFLECTION IN BIN (WORKING SET) : 752 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2760 REMARK 3 BIN FREE R VALUE SET COUNT : 40 REMARK 3 BIN FREE R VALUE : 0.3860 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3498 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 138 REMARK 3 SOLVENT ATOMS : 26 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.86 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.76000 REMARK 3 B22 (A**2) : -2.13000 REMARK 3 B33 (A**2) : 2.90000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.451 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.347 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 17.993 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.928 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.917 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3735 ; 0.006 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5071 ; 0.910 ; 2.048 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 427 ; 4.231 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 181 ;35.114 ;23.923 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 635 ;16.523 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;13.759 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 525 ; 0.061 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2866 ; 0.003 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2159 ; 0.328 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3474 ; 0.602 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1576 ; 0.503 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1597 ; 0.912 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3TGM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-AUG-11. REMARK 100 THE DEPOSITION ID IS D_1000067452. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-MAR-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979300 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : 3.3 UNDULATOR (UNDULATOR A) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XSCALE REMARK 200 DATA SCALING SOFTWARE : XSCALE, XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11070 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.750 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 200 DATA REDUNDANCY : 2.630 REMARK 200 R MERGE (I) : 0.09900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.2600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.97200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1N3U CHAIN A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM HEPES (PH 7.5), 2.2 M AMMONIUM REMARK 280 SULFATE, 0.95% 1,6-HEXANEDIOL, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.30500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.64000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.49000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.64000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.30500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.49000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 ARG A 3 REMARK 465 PRO A 4 REMARK 465 GLN A 5 REMARK 465 PRO A 6 REMARK 465 ASP A 7 REMARK 465 SER A 8 REMARK 465 MET A 9 REMARK 465 ASP A 224 REMARK 465 THR A 225 REMARK 465 LYS A 226 REMARK 465 ASP A 227 REMARK 465 GLN A 228 REMARK 465 SER A 229 REMARK 465 PRO A 230 REMARK 465 SER A 231 REMARK 465 ARG A 232 REMARK 465 ALA A 233 REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 ARG B 3 REMARK 465 PRO B 4 REMARK 465 GLN B 5 REMARK 465 PRO B 6 REMARK 465 ASP B 7 REMARK 465 SER B 8 REMARK 465 MET B 9 REMARK 465 THR B 225 REMARK 465 LYS B 226 REMARK 465 ASP B 227 REMARK 465 GLN B 228 REMARK 465 SER B 229 REMARK 465 PRO B 230 REMARK 465 SER B 231 REMARK 465 ARG B 232 REMARK 465 ALA B 233 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 41 57.86 -95.33 REMARK 500 ARG A 100 32.08 -98.83 REMARK 500 PRO A 193 -7.02 -57.09 REMARK 500 THR A 222 49.07 -99.28 REMARK 500 PHE B 74 -32.43 -134.90 REMARK 500 SER B 159 49.58 -78.15 REMARK 500 HIS B 223 93.23 -60.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 300 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 25 NE2 REMARK 620 2 HEM A 300 NA 86.6 REMARK 620 3 HEM A 300 NB 89.6 90.8 REMARK 620 4 HEM A 300 NC 92.6 179.3 89.0 REMARK 620 5 HEM A 300 ND 91.5 88.8 178.8 91.4 REMARK 620 6 3TG A 301 NAQ 174.6 89.5 86.6 91.2 92.3 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 300 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 25 NE2 REMARK 620 2 HEM B 300 NA 82.6 REMARK 620 3 HEM B 300 NB 94.9 89.7 REMARK 620 4 HEM B 300 NC 95.0 177.3 89.2 REMARK 620 5 HEM B 300 ND 83.4 89.3 178.2 91.7 REMARK 620 6 3TG B 301 NAQ 170.6 91.4 92.2 91.2 89.3 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3TG A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3TG B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEZ A 234 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3CZY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN HEME OXYGENASE-1 IN COMPLEX WITH 1- REMARK 900 (ADAMANTAN-1-YL)-2-(1H-IMIDAZOL-1-YL)ETHANONE REMARK 900 RELATED ID: 3HOK RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HUMAN HEME OXYGENASE-1 WITH (2R, 4S)-2- REMARK 900 [2-(4-CHLOROPHENYL)ETHYL]-2-[(1H-IMIDAZOL-1-YL)METHYL]-4[((5- REMARK 900 TRIFLUOROMETHYLPYRIDIN-2-YL)THIO)METHYL]-1,3-DIOXOLANE REMARK 900 RELATED ID: 3K4F RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HUMAN HEME OXYGENASE-1 IN COMPLEX WITH 4- REMARK 900 PHENYL-1-(1H-1,2,4-TRIAZOL-1-YL)-2-BUTANONE REMARK 900 RELATED ID: 1N45 RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HUMAN HEME OXYGENASE-1 (HO-1) IN COMPLEX REMARK 900 WITH ITS SUBSTRATE HEME DBREF 3TGM A 1 233 UNP P09601 HMOX1_HUMAN 1 233 DBREF 3TGM B 1 233 UNP P09601 HMOX1_HUMAN 1 233 SEQRES 1 A 233 MET GLU ARG PRO GLN PRO ASP SER MET PRO GLN ASP LEU SEQRES 2 A 233 SER GLU ALA LEU LYS GLU ALA THR LYS GLU VAL HIS THR SEQRES 3 A 233 GLN ALA GLU ASN ALA GLU PHE MET ARG ASN PHE GLN LYS SEQRES 4 A 233 GLY GLN VAL THR ARG ASP GLY PHE LYS LEU VAL MET ALA SEQRES 5 A 233 SER LEU TYR HIS ILE TYR VAL ALA LEU GLU GLU GLU ILE SEQRES 6 A 233 GLU ARG ASN LYS GLU SER PRO VAL PHE ALA PRO VAL TYR SEQRES 7 A 233 PHE PRO GLU GLU LEU HIS ARG LYS ALA ALA LEU GLU GLN SEQRES 8 A 233 ASP LEU ALA PHE TRP TYR GLY PRO ARG TRP GLN GLU VAL SEQRES 9 A 233 ILE PRO TYR THR PRO ALA MET GLN ARG TYR VAL LYS ARG SEQRES 10 A 233 LEU HIS GLU VAL GLY ARG THR GLU PRO GLU LEU LEU VAL SEQRES 11 A 233 ALA HIS ALA TYR THR ARG TYR LEU GLY ASP LEU SER GLY SEQRES 12 A 233 GLY GLN VAL LEU LYS LYS ILE ALA GLN LYS ALA LEU ASP SEQRES 13 A 233 LEU PRO SER SER GLY GLU GLY LEU ALA PHE PHE THR PHE SEQRES 14 A 233 PRO ASN ILE ALA SER ALA THR LYS PHE LYS GLN LEU TYR SEQRES 15 A 233 ARG SER ARG MET ASN SER LEU GLU MET THR PRO ALA VAL SEQRES 16 A 233 ARG GLN ARG VAL ILE GLU GLU ALA LYS THR ALA PHE LEU SEQRES 17 A 233 LEU ASN ILE GLN LEU PHE GLU GLU LEU GLN GLU LEU LEU SEQRES 18 A 233 THR HIS ASP THR LYS ASP GLN SER PRO SER ARG ALA SEQRES 1 B 233 MET GLU ARG PRO GLN PRO ASP SER MET PRO GLN ASP LEU SEQRES 2 B 233 SER GLU ALA LEU LYS GLU ALA THR LYS GLU VAL HIS THR SEQRES 3 B 233 GLN ALA GLU ASN ALA GLU PHE MET ARG ASN PHE GLN LYS SEQRES 4 B 233 GLY GLN VAL THR ARG ASP GLY PHE LYS LEU VAL MET ALA SEQRES 5 B 233 SER LEU TYR HIS ILE TYR VAL ALA LEU GLU GLU GLU ILE SEQRES 6 B 233 GLU ARG ASN LYS GLU SER PRO VAL PHE ALA PRO VAL TYR SEQRES 7 B 233 PHE PRO GLU GLU LEU HIS ARG LYS ALA ALA LEU GLU GLN SEQRES 8 B 233 ASP LEU ALA PHE TRP TYR GLY PRO ARG TRP GLN GLU VAL SEQRES 9 B 233 ILE PRO TYR THR PRO ALA MET GLN ARG TYR VAL LYS ARG SEQRES 10 B 233 LEU HIS GLU VAL GLY ARG THR GLU PRO GLU LEU LEU VAL SEQRES 11 B 233 ALA HIS ALA TYR THR ARG TYR LEU GLY ASP LEU SER GLY SEQRES 12 B 233 GLY GLN VAL LEU LYS LYS ILE ALA GLN LYS ALA LEU ASP SEQRES 13 B 233 LEU PRO SER SER GLY GLU GLY LEU ALA PHE PHE THR PHE SEQRES 14 B 233 PRO ASN ILE ALA SER ALA THR LYS PHE LYS GLN LEU TYR SEQRES 15 B 233 ARG SER ARG MET ASN SER LEU GLU MET THR PRO ALA VAL SEQRES 16 B 233 ARG GLN ARG VAL ILE GLU GLU ALA LYS THR ALA PHE LEU SEQRES 17 B 233 LEU ASN ILE GLN LEU PHE GLU GLU LEU GLN GLU LEU LEU SEQRES 18 B 233 THR HIS ASP THR LYS ASP GLN SER PRO SER ARG ALA HET HEM A 300 43 HET 3TG A 301 22 HET HEZ A 234 8 HET HEM B 300 43 HET 3TG B 301 22 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM 3TG 1-(1H-IMIDAZOL-1-YL)-4,4-DIPHENYLBUTAN-2-ONE HETNAM HEZ HEXANE-1,6-DIOL HETSYN HEM HEME FORMUL 3 HEM 2(C34 H32 FE N4 O4) FORMUL 4 3TG 2(C19 H18 N2 O) FORMUL 5 HEZ C6 H14 O2 FORMUL 8 HOH *26(H2 O) HELIX 1 1 ASP A 12 THR A 21 1 10 HELIX 2 2 THR A 21 ASN A 30 1 10 HELIX 3 3 ALA A 31 LYS A 39 1 9 HELIX 4 4 THR A 43 LYS A 69 1 27 HELIX 5 5 PHE A 74 TYR A 78 5 5 HELIX 6 6 PHE A 79 HIS A 84 1 6 HELIX 7 7 ARG A 85 GLY A 98 1 14 HELIX 8 8 ARG A 100 ILE A 105 1 6 HELIX 9 9 THR A 108 GLU A 125 1 18 HELIX 10 10 LEU A 128 ASP A 156 1 29 HELIX 11 11 LEU A 164 THR A 168 5 5 HELIX 12 12 SER A 174 SER A 188 1 15 HELIX 13 13 ALA A 194 THR A 222 1 29 HELIX 14 14 ASP B 12 THR B 21 1 10 HELIX 15 15 THR B 21 ASN B 30 1 10 HELIX 16 16 ALA B 31 LYS B 39 1 9 HELIX 17 17 THR B 43 ASN B 68 1 26 HELIX 18 18 PHE B 74 TYR B 78 5 5 HELIX 19 19 PHE B 79 HIS B 84 1 6 HELIX 20 20 ARG B 85 GLY B 98 1 14 HELIX 21 21 ARG B 100 ILE B 105 1 6 HELIX 22 22 THR B 108 THR B 124 1 17 HELIX 23 23 GLU B 125 GLU B 127 5 3 HELIX 24 24 LEU B 128 GLY B 144 1 17 HELIX 25 25 GLY B 144 ASP B 156 1 13 HELIX 26 26 LEU B 164 THR B 168 5 5 HELIX 27 27 SER B 174 ASN B 187 1 14 HELIX 28 28 THR B 192 HIS B 223 1 32 LINK NE2 HIS A 25 FE HEM A 300 1555 1555 2.10 LINK FE HEM A 300 NAQ 3TG A 301 1555 1555 2.15 LINK NE2 HIS B 25 FE HEM B 300 1555 1555 2.37 LINK FE HEM B 300 NAQ 3TG B 301 1555 1555 2.09 SITE 1 AC1 12 HIS A 25 GLU A 29 MET A 34 GLN A 38 SITE 2 AC1 12 TYR A 134 THR A 135 GLY A 139 LYS A 179 SITE 3 AC1 12 ARG A 183 PHE A 207 ASN A 210 3TG A 301 SITE 1 AC2 11 PHE A 37 VAL A 50 ARG A 136 GLY A 139 SITE 2 AC2 11 ASP A 140 GLY A 143 LEU A 147 PHE A 167 SITE 3 AC2 11 ASN A 210 PHE A 214 HEM A 300 SITE 1 AC3 10 HIS B 25 MET B 34 TYR B 134 THR B 135 SITE 2 AC3 10 GLY B 139 ARG B 183 PHE B 207 ASN B 210 SITE 3 AC3 10 PHE B 214 3TG B 301 SITE 1 AC4 11 MET B 34 VAL B 50 ARG B 136 GLY B 139 SITE 2 AC4 11 ASP B 140 GLY B 143 LEU B 147 PHE B 167 SITE 3 AC4 11 ASN B 210 PHE B 214 HEM B 300 SITE 1 AC5 7 GLU A 62 GLU A 66 VAL A 77 PHE A 79 SITE 2 AC5 7 PRO A 80 HIS A 84 TYR A 137 CRYST1 54.610 74.980 115.280 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018312 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013337 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008675 0.00000